Results 111 to 120 of about 49,723 (153)

[Early-onset Colorectal Cancer: Epidemiological and Clinical Characteristics and Survival Analysis in a Hospital Cohort]. [PDF]

open access: yesActa Gastroenterol Latinoam
Balmaceda R   +5 more
europepmc   +1 more source

[[Supravalvular pulmonary stenosis as a manifestation of a mediastinal germ cell tumor: a case report]]. [PDF]

open access: yesArch Peru Cardiol Cir Cardiovasc
García-Saavedra MB   +7 more
europepmc   +1 more source

[Clinical spectrum, neuroimaging and therapeutic response to neurological syndromes associated with anti-GAD65]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Hernández-Salomón LF   +5 more
europepmc   +1 more source

[Long-term outcomes of maxillectomy for paranasal sinus cancer]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Ramírez-Echavarría A   +4 more
europepmc   +1 more source

[Neuroendocrine expression markers in triple-negative, luminal-A, luminal-B and HER2neu breast cancer]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Barboza-García YG   +4 more
europepmc   +1 more source

[Pattern of invasive growth of pituitary adenomas with positive hormonal immunohistochemistry]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Bello-Lemus VH   +2 more
europepmc   +1 more source

Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107). [PDF]

open access: yesJ Clin Oncol
Garcia-Carbonero R   +24 more
europepmc   +1 more source

[Solid Pseudopapillary Neoplasm of the Pancreas: Diagnosis and Surgical Management in a Young Patient]. [PDF]

open access: yesActa Gastroenterol Latinoam
García Alba EL   +6 more
europepmc   +1 more source

Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914). [PDF]

open access: yesClin Cancer Res
Capdevila J   +19 more
europepmc   +1 more source

Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial. [PDF]

open access: yesESMO Open
Capdevila J   +41 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy